发明名称 |
Compounds for treating Rac-GPTase mediated disorder |
摘要 |
<p>This disclosure relates to compositions including certain compounds identified by a quantitative, high throughput assay to be effective in the treatment of chronic myelogenous leukemia, as well as methods for the manufacture of and the use of these compounds for treating a Rac-GTPase mediated disorder.</p> |
申请公布号 |
AU2013328979(A1) |
申请公布日期 |
2015.05.07 |
申请号 |
AU20130328979 |
申请日期 |
2013.10.11 |
申请人 |
CHILDREN'S MEDICAL CENTER CORPORATION |
发明人 |
WILLIAMS, DAVID A. |
分类号 |
A61K31/497;A61K31/4162;A61K31/4184;A61K31/495;A61P19/00;A61P29/00;A61P35/00 |
主分类号 |
A61K31/497 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|